Skip to main content
Skip to footer
Home
Home
About
Overview
Management Team
Board of Directors
Medical & Scientific Advisors
Alzheimer’s
Overview
AD Clinics
Markets
Resources
Pipeline
Overview
NP-251 (Repirinast)
AP-188 (DMT)
Companies
Algernon NeuroScience
News & Media
News Releases
IR Calendar
Presentations
Videos/Articles
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEDAR
Governance
Contact
Presentations
Aug 25, 2023
Corporate Fact Sheet August 2023
Aug 24, 2023
Algernon Presentation Q3 2023
Mar 15, 2023
Algernon Presentation Q1 2023
rss_feed
RSS
Facebook
Twitter
LinkedIn
Email Alerts
